Syndrome

Brazilian SARS-CoV-2 P.1 differentiation exhibits resistance to antibody neutralization

Studies suggest that there is no protection against SARS-CoV-2 infections from recent exposure to HCoVs

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 difference

Results of a phase 2 trial of the Novavax reconstituted SARS-CoV-2 nanoparticle vaccine

Genetic mutation associated with COVID-19 production

Pfizer SARS-CoV-2 vaccine effective from day 11 after 1d vaccine

A very severe form of COVID-19 in children exhibits specific features of the virus

How SARS-CoV-2 proteins affect biologic activity

Study showing long-term neuropsychological effects after SARS-CoV-2 infection

Measuring SARS-CoV-2 viral pressure in hospitalized patients